Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2004

Conditions

Metabolic SyndromeFamilial HypertriglyceridemiaFamilial Combined Hyperlipidemia

Interventions

DRUG

chenodeoxycholic acid

chenodeoxycholic acid 500 mg capsules tid po

DRUG

placebo capsules

placebo capsules containing mannitol tid po

Trial Locations (1)

University Hospital Basel, Basel

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER

NCT00465751 - Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism | Biotech Hunter | Biotech Hunter